These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 28526303

  • 1. The use of Biobrane® for wound coverage in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Rogers AD, Blackport E, Cartotto R.
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [Abstract] [Full Text] [Related]

  • 2. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M, Ward JA, Frew Q, Gerrish H, Martin N, Shaw A, Barnes D, Shelly O, Philp B, El-Muttardi N, Dziewulski P.
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [Abstract] [Full Text] [Related]

  • 3. The use of porcine xenografts in patients with toxic epidermal necrolysis.
    Young JB, Gondek SP, Troche M, Summitt JB, Rae L, Thayer WP, Kahn SA.
    Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163
    [Abstract] [Full Text] [Related]

  • 4. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A, Sikora S, Evans M, Song D, Kirchhof M, Miliszewski M, Dutz J.
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [Abstract] [Full Text] [Related]

  • 5. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M, Burg M, Lin E, Peng D, Garner W.
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [Abstract] [Full Text] [Related]

  • 6. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D, Egipto P, Barbosa J, Horta R, Amarante J, Silva P, Silva A.
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [Abstract] [Full Text] [Related]

  • 7. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
    Davis JS, Pandya RK, Pizano LR, Namias N, Dearwater S, Schulman CI.
    J Burn Care Res; 2013 Jun; 34(5):492-7. PubMed ID: 23966120
    [Abstract] [Full Text] [Related]

  • 8. Toxic epidermal necrolysis: a review and report of the successful use of Biobrane for early wound coverage.
    Bradley T, Brown RE, Kucan JO, Smoot EC, Hussmann J.
    Ann Plast Surg; 1995 Aug; 35(2):124-32. PubMed ID: 7486733
    [Abstract] [Full Text] [Related]

  • 9. Antishear Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Follow-up Study.
    Haravu PN, Gottlieb LJ, Vrouwe SQ.
    J Burn Care Res; 2021 Nov 24; 42(6):1152-1161. PubMed ID: 34370855
    [Abstract] [Full Text] [Related]

  • 10. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
    Lewcun JA, Vagonis A, Kontzias C, Newsom M, Drake M, Feldman MJ.
    J Burn Care Res; 2024 Jan 05; 45(1):165-168. PubMed ID: 37698266
    [Abstract] [Full Text] [Related]

  • 11. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C, Xu W, Perbix W, Lefering R, Maegele M, Rathert M, Spilker G.
    Burns; 2013 Nov 05; 39(7):1449-55. PubMed ID: 23702222
    [Abstract] [Full Text] [Related]

  • 12. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.
    Am J Ophthalmol; 2010 Oct 05; 150(4):505-510.e1. PubMed ID: 20619392
    [Abstract] [Full Text] [Related]

  • 13. Biobrane versus topical agents in the treatment of adult scald burns.
    Krezdorn N, Könneker S, Paprottka FJ, Tapking C, Mett TR, Brölsch GF, Boyce M, Ipaktchi R, Vogt PM.
    Burns; 2017 Feb 05; 43(1):195-199. PubMed ID: 27507189
    [Abstract] [Full Text] [Related]

  • 14. Use of Biobrane in the treatment of toxic epidermal necrolysis.
    Kucan JO.
    J Burn Care Rehabil; 1995 Feb 05; 16(3 Pt 1):324-7; discussion 327-8. PubMed ID: 7673317
    [Abstract] [Full Text] [Related]

  • 15. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN/Stevens-Johnson syndrome overlap.
    Smith SD, Dodds A, Dixit S, Cooper A.
    Australas J Dermatol; 2015 Nov 05; 56(4):298-302. PubMed ID: 25368980
    [Abstract] [Full Text] [Related]

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
    Houschyar KS, Tapking C, Borrelli MR, Nietzschmann I, Puladi B, Ooms M, Rein S, Houschyar M, Duscher D, Maan ZN, Reumuth G, Branski LK, Modabber A, Kluwig D, Schmitt L, Philipp-Dormston WG, Yazdi AS, Siemers F.
    J Wound Care; 2021 Jun 02; 30(6):492-496. PubMed ID: 34121430
    [Abstract] [Full Text] [Related]

  • 17. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM, Do A, Berger TG, Nguyen AH, DeWeese J, Malone JD, Jordan K, Hom F, Tuffanelli L, Fillari P, Siu S, Grossman R.
    Burns; 2016 Jun 02; 42(4):836-43. PubMed ID: 26847613
    [Abstract] [Full Text] [Related]

  • 18. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers.
    Nygaard RM, Endorf FW.
    J Burn Care Res; 2020 Sep 23; 41(5):945-950. PubMed ID: 32498082
    [Abstract] [Full Text] [Related]

  • 19. Biobrane wound dressing used in the treatment of toxic epidermal necrolysis: a case report.
    Sowder LL.
    J Burn Care Rehabil; 1990 Sep 23; 11(3):237-9. PubMed ID: 2373732
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.